AFP and hepatocellular carcinoma: Taking into consideration the capacity of discrimination in early HCC cases, the sAUC of AFP, respectively, PIVKA II were 0.740 (CI 95% 0.694 to 0.787), respectively, 0.790 (95% CI 0.751 to 0.828)–data were reported in Figure 3.